#NRP2
Issue 22 is now complete!

On the cover: Dermal skin of an E14.5 Cxcl12-DsRed mouse embryo whole mount stained for the lymphatic endothelial cell marker Nrp2 (green), RFP (magenta) and the peripheral nerve marker Tuj1 (blue). See Research article by Do et al.
https://doi.org/10.1242/dev.202901
December 4, 2024 at 12:06 PM
🎙️ MICK LYNCH with A Celtic State of Mind.

📺 Watch the full episode of This is ACSOM here: m.youtube.com/watch?v=nrP2...
April 2, 2025 at 10:40 PM
Knockout of key receptors (PDGFRA and NRP2) in the guinea pig model blocks direct and endocytic pathways of CMV cell entry. Published Open Access and fee-free in JGV using a Publish and Read agreement: https://doi.org/10.1099/jgv.0.002236 #PublishandRead #JGV
April 26, 2026 at 3:00 PM
NRP2 is a target for resolving lung inflammation by a therapeutic histidyl-tRNA synthetase splice variant
www.science.org/doi/10.1126/...
March 13, 2025 at 3:29 AM
Nouveau clip des #Perfume à découvrir à partir de demain 11h30
youtu.be/zMAgUP51HwU

Album "Nebula Romance part2" bientôt disponible en numérique
prfm.lnk.to/NRP2
[Official Music Video] Perfume 『巡ループ』
YouTube video by Perfume
youtu.be
August 17, 2025 at 9:27 PM
HARSWHEP binds NRP2 to modulate lung inflammation and fibrosis.
A histidyl-tRNA synthetase splice variant suppresses proinflammatory signaling in macrophages, reducing immune cell infiltration and fibrosis in ILD models.

Science Translational Medicine: www.science.org/doi/10.1126/...
A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis
NRP2 is a target for resolving lung inflammation by a therapeutic histidyl-tRNA synthetase splice variant.
www.science.org
March 14, 2025 at 12:30 AM
scRNAseq👤#PreretinalFibrovascularMembrane
#DiabeticRetinopathy
N=4

AEBP1➡️#Pericyte-to-Myofibroblast transformation

Pericyte-#EndothelialCell
VEGFA-FLT1/KDR

Myofibroblast/SMC-EC
Sema3C-Nrp2; VEGFA/VEGFC-FLT1/KDR/FLT4

#JCIInsight 2023
insight.jci.org/articles/vie...
November 16, 2023 at 8:08 PM
HARS WHEP adlı bir protein, NRP2 reseptörüne bağlanarak bağışıklık hücrelerini (makrofajları) daha az iltihaplı bir yapıya dönüştürüyor. Bu sayede doku hasarı ve fibrozis oluşumu engellenebiliyor.
April 8, 2025 at 1:29 PM
University Hospital Bonn examined 20 autopsies and found that neuropilin-1 and neuropilin-2, not ACE2, were present in key cells infected by SARS-CoV-2, suggesting these proteins help the virus spread and may drive long COVID complications.

journals.asm.org/doi/10.1128/...
Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19 | Journal of Virology
The well-known severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor, angiotensin-converting enzyme 2 (ACE2), exhibits low expression in key cell types implicated in coronavirus disease 2019 (COVID-19) pathology, such as endothelial cells and B cells, macrophages, and mast cells. In contrast, neuropilins, identified as co-receptors for SARS-CoV-2, are abundantly expressed in these cells under physiological conditions and may be involved in virus-host interactions. This study presents a detailed in situ analysis of Neuropilin 1 (NRP1) and Neuropilin 2 (NRP2) expression in fatal COVID-19 cases using immunohistochemistry and spatial multiplex immunofluorescence phenotyping, complemented by single cell RNA sequencing. Additionally, it demonstrates differential binding affinities of NRP1 and NRP2 to SARS-CoV-2 spike protein fragments S1 and S1′ in vitro, suggesting distinct roles for these neuropilins in viral recognition. This study highlights the impact of the unique furin cleavage site in SARS-CoV-2, which may contribute to increased pathogenicity through its interaction with NRP1.
journals.asm.org
November 4, 2025 at 12:45 AM
Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19 journals.asm.org/doi/10.1128/...
Differential expression of viral entry protein neuropilin 1 (NRP1) and neuropilin 2 (NRP2) in fatal COVID-19 | Journal of Virology
The well-known severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor, angiotensin-converting enzyme 2 (ACE2), exhibits low expression in key cell types implicated in coronavirus diseas...
journals.asm.org
October 29, 2025 at 1:52 PM
🧪 Recombinant anti-NRP1 antibodies from @ipiproteins.bsky.social are now available at Addgene. Researchers can use IPI-mNRP1.17 and IPI-mNRP1.23 for FC, IHC, and ICC in mouse and human — with no cross-reactivity to NRP2. 🎯
Check out the antibodies here:
Addgene: IPI Antibody Collection
Find unique recombinant antibodies targeting families of cell surface and secreted proteins from a collaboration between Addgene and IPI.
twp.ai
July 7, 2026 at 7:01 PM
This month, Dr. Harsh Dongre from Boston Children’s Hospital will present his research on #NRP2 and #TumorDevelopment! Register now for this #VirtualSeminar https://bit.ly/4fLoqu7
#ASIPwebinar #pathobiology
August 6, 2026 at 3:35 PM
Next month, Dr. Harsh Dongre from Boston Children’s Hospital will present his research on #NRP2 and #TumorDevelopment! Register now for this #VirtualSeminar bit.ly/4fLoqu7

#ASIPwebinar #pathobiology
July 21, 2026 at 2:00 PM
Knockout of key receptors (PDGFRA and NRP2) in the guinea pig model blocks direct and endocytic pathways of CMV cell entry

www.microbiologyresearch.org/content/jour...
Knockout of key receptors (PDGFRA and NRP2) in the guinea pig model blocks direct and endocytic pathways of CMV cell entry
The guinea pig with guinea pig cytomegalovirus (GPCMV) is the only small-animal model for congenital cytomegalovirus, a leading cause of cognitive impairment and hearing loss in newborns. GPCMV encode...
www.microbiologyresearch.org
March 11, 2026 at 1:25 PM
New antibody alert 🧪

➕ Anti-#SEMA3A/C/D/E/F
➕ Anti-#NRP2
➕ Anti-#CNTN2 (TAG-1)

IPI #recombinantmonoclonals are designed to be mouse/human reactive, do not cross-react w/other protein family members & are IPI-validated for #flowcytometry/ #immunofluorescence.

View the datasheets: buff.ly/7SE9WnB
Axon Guidance Antibody Collection
For neurons to communicate, their axons must navigate precisely to their targets through a complex process known as axon guidance or neuronal migration. This pr
buff.ly
June 1, 2026 at 5:00 PM
youtube.com/watch?v=nrP2... ACSOM Mick Lynch : This guy would be cracking to meet in the boozer just a really switched on guy. Must watch for all persuasions ✊
youtube.com
November 18, 2024 at 6:53 PM
"Together, our findings show that disruption of developmental Nrp2 regulation of interneuron circuit establishment, produces ASD-like behaviors and enhanced risk for epilepsy. These results support the developmental interneuronopathy hypothesis of ASD epilepsy comorbidity." […]
Original post on mastodon.social
mastodon.social
January 20, 2025 at 10:44 PM
Feed: "The Journal of Clinical Investigation -- New Articles"
By: Johannes Wedel, Nora Kochupurakkal, Sek Won Kong, Sayantan Bose, Ji-Won Lee, Madeline Maslyar, Bayan Alsairafi, Kayla MacLeod, Kaifeng Liu, Hengcheng Zhang, Masaki Komatsu, Hironao Nakayama, Diane R. Bielenberg, David M. Briscoe
Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection
Coinhibitory receptors function as central modulators of the immune response to resolve T effector activation and/or to sustain immune homeostasis. Here, using humanized SCID mice, we found that neuropilin–2 (NRP2) is inducible on late effector and exhausted subsets of human CD4+ T cells and that it is coexpressed with established coinhibitory molecules including PD-1, CTLA4, TIGIT, LAG3, and TIM3. In murine models, we also found that NRP2 is expressed on effector memory CD4+ T cells with an exhausted phenotype and that it functions as a key coinhibitory molecule. Knockout (KO) of NRP2 resulted in hyperactive CD4+ T cell responses and enhanced inflammation in delayed-type hypersensitivity and transplantation models. After cardiac transplantation, allograft rejection and graft failure were accelerated in global as well as CD4+ T cell–specific KO recipients, and enhanced alloimmunity was dependent on NRP2 expression on CD4+ T effectors but not on CD4+Foxp3+ Tregs. Also, KO Tregs were found to be as efficient as WT cells in the suppression of effector responses in vitro and in vivo. These collective findings identify NRP2 as a potentially novel coinhibitory receptor and demonstrate that its expression on CD4+ T effector cells is of great functional importance in immunity.
www.jci.org
July 3, 2025 at 11:06 PM
Parts 1-2/2 — EFTA01716182.jpg
#epsteinweb #efta01716182
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
March 7, 2026 at 9:29 PM
Parts 1-2/2 — EFTA01716178.jpg
#epsteinweb #efta01716178
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
March 7, 2026 at 9:28 PM
Parts 1-2/2 — EFTA01716157.jpg
#epsteinweb #efta01716157
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
March 7, 2026 at 9:27 PM